356 related articles for article (PubMed ID: 32870468)
1. Implications of Transient Receptor Potential Cation Channels in Migraine Pathophysiology.
Shibata M; Tang C
Neurosci Bull; 2021 Jan; 37(1):103-116. PubMed ID: 32870468
[TBL] [Abstract][Full Text] [Related]
2. The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system.
Citak A; Kilinc E; Torun IE; Ankarali S; Dagistan Y; Yoldas H
Cephalalgia; 2022 Nov; 42(13):1375-1386. PubMed ID: 35861239
[TBL] [Abstract][Full Text] [Related]
3. Expression of the transient receptor potential channels TRPV1, TRPA1 and TRPM8 in mouse trigeminal primary afferent neurons innervating the dura.
Huang D; Li S; Dhaka A; Story GM; Cao YQ
Mol Pain; 2012 Sep; 8():66. PubMed ID: 22971321
[TBL] [Abstract][Full Text] [Related]
4. TRP Channels: Recent Development in Translational Research and Potential Therapeutic Targets in Migraine.
Spekker E; Körtési T; Vécsei L
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614146
[TBL] [Abstract][Full Text] [Related]
5. Functional interactions between transient receptor potential M8 and transient receptor potential V1 in the trigeminal system: Relevance to migraine pathophysiology.
Kayama Y; Shibata M; Takizawa T; Ibata K; Shimizu T; Ebine T; Toriumi H; Yuzaki M; Suzuki N
Cephalalgia; 2018 Apr; 38(5):833-845. PubMed ID: 28554243
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Connections of the TRPA1 Ion Channel in Pain Transmission and Neurogenic Inflammation - a Therapeutic Perspective in Migraine?
Fila M; Pawlowska E; Szczepanska J; Blasiak J
Mol Neurobiol; 2023 Oct; 60(10):5578-5591. PubMed ID: 37326902
[TBL] [Abstract][Full Text] [Related]
7. TRPA1 and other TRP channels in migraine.
Benemei S; De Cesaris F; Fusi C; Rossi E; Lupi C; Geppetti P
J Headache Pain; 2013 Aug; 14(1):71. PubMed ID: 23941062
[TBL] [Abstract][Full Text] [Related]
8. The TRPA1 channel in migraine mechanism and treatment.
Benemei S; Fusi C; Trevisan G; Geppetti P
Br J Pharmacol; 2014 May; 171(10):2552-67. PubMed ID: 24206166
[TBL] [Abstract][Full Text] [Related]
9. The role of TRP ion channels in migraine and headache.
Iannone LF; De Logu F; Geppetti P; De Cesaris F
Neurosci Lett; 2022 Jan; 768():136380. PubMed ID: 34861342
[TBL] [Abstract][Full Text] [Related]
10. CGRP and the Trigeminal System in Migraine.
Iyengar S; Johnson KW; Ossipov MH; Aurora SK
Headache; 2019 May; 59(5):659-681. PubMed ID: 30982963
[TBL] [Abstract][Full Text] [Related]
11. Targeting TRP channels for novel migraine therapeutics.
Dussor G; Yan J; Xie JY; Ossipov MH; Dodick DW; Porreca F
ACS Chem Neurosci; 2014 Nov; 5(11):1085-96. PubMed ID: 25138211
[TBL] [Abstract][Full Text] [Related]
12. Petasin and isopetasin reduce CGRP release from trigeminal afferents indicating an inhibitory effect on TRPA1 and TRPV1 receptor channels.
Kleeberg-Hartmann J; Vogler B; Messlinger K
J Headache Pain; 2021 Apr; 22(1):23. PubMed ID: 33849430
[TBL] [Abstract][Full Text] [Related]
13. Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology.
Thalakoti S; Patil VV; Damodaram S; Vause CV; Langford LE; Freeman SE; Durham PL
Headache; 2007; 47(7):1008-23; discussion 24-5. PubMed ID: 17635592
[TBL] [Abstract][Full Text] [Related]
14. OnabotulinumtoxinA effects on trigeminal nociceptors.
Moore AA; Nelson M; Wickware C; Choi S; Moon G; Xiong E; Orta L; Brideau-Andersen A; Brin MF; Broide RS; Liedtke W; Moore C
Cephalalgia; 2023 Feb; 43(2):3331024221141683. PubMed ID: 36751871
[TBL] [Abstract][Full Text] [Related]
15. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy.
Durham PL; Cady R; Cady R
Headache; 2004 Jan; 44(1):35-42; discussion 42-3. PubMed ID: 14979881
[TBL] [Abstract][Full Text] [Related]
16. The role of the transient receptor potential ankyrin type-1 (TRPA1) channel in migraine pain: evaluation in an animal model.
Demartini C; Tassorelli C; Zanaboni AM; Tonsi G; Francesconi O; Nativi C; Greco R
J Headache Pain; 2017 Sep; 18(1):94. PubMed ID: 28884307
[TBL] [Abstract][Full Text] [Related]
17. Current understanding of trigeminal ganglion structure and function in headache.
Messlinger K; Russo AF
Cephalalgia; 2019 Nov; 39(13):1661-1674. PubMed ID: 29989427
[TBL] [Abstract][Full Text] [Related]
18. The role of calcitonin gene-related peptide on the increase in transient receptor potential vanilloid-1 levels in trigeminal ganglion and trigeminal nucleus caudalis activation of rat.
Chatchaisak D; Srikiatkhachorn A; Maneesri-le Grand S; Govitrapong P; Chetsawang B
J Chem Neuroanat; 2013 Jan; 47():50-6. PubMed ID: 23123284
[TBL] [Abstract][Full Text] [Related]
19. TRPA1/NOX in the soma of trigeminal ganglion neurons mediates migraine-related pain of glyceryl trinitrate in mice.
Marone IM; De Logu F; Nassini R; De Carvalho Goncalves M; Benemei S; Ferreira J; Jain P; Li Puma S; Bunnett NW; Geppetti P; Materazzi S
Brain; 2018 Aug; 141(8):2312-2328. PubMed ID: 29985973
[TBL] [Abstract][Full Text] [Related]
20. Parthenolide inhibits nociception and neurogenic vasodilatation in the trigeminovascular system by targeting the TRPA1 channel.
Materazzi S; Benemei S; Fusi C; Gualdani R; De Siena G; Vastani N; Andersson DA; Trevisan G; Moncelli MR; Wei X; Dussor G; Pollastro F; Patacchini R; Appendino G; Geppetti P; Nassini R
Pain; 2013 Dec; 154(12):2750-2758. PubMed ID: 23933184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
